SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coherent (COHR) : Anyone else holding?
COHR 163.48+5.8%10:36 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas J Pittman who wrote (336)12/2/1997 2:35:00 PM
From: Doug  Read Replies (1) of 788
 
Hi Thomas: You havent missed anything in the release but it appears you are now erroneously connecting patients to total machine sales. The sales for Glaucoma Lasers are expected to be $15m presumably per year. To determine the cost per patient, one needs to know the No of machines, the serviceablity factor, the no of visits/patient and the time for each proceedure.
The release that will drive COHR concerns the DUV Photolith Laser
used for marking the photomask of the next generation of 0.07-15U line
width wafers. This is a big ticker item.
Good luck.!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext